[Case of tuberculous epididymitis caused by intravesical BCG therapy].

T. Koizumi,R. Nakanishi,R. Taue,K. Yamaguchi,H. Nakatuji,T. Kishimoto,H. Izaki,N. Oka,Masayuki Takahashi,T. Fukumori,H. Kanayama
2008-09-01
Abstract:Intravesical Bacillus Calmette-Guerin (BCG) therapy is commonly used against superficial urothelial carcinoma, especially carcinoma in situ (CIS). We report a case of tuberculous epididymitis that occurred during a course of intravesical BCG therapy. A 76-year-old man had received intravesical BCG therapy for multiple superficial bladder cancer and CIS in prostatic urethra after transurethral resection of bladder tumor (TUR-Bt). He recognized hard nodules in the left scrotum after 4 times intravesical BCG therapy. Skin fistula in scrotum occurred 5 months later. We performed left orchiectomy with scrotum skin resection. Histological diagnosis was tuberculous epididymitis. Postoperatively, he was administered chemotherapy consisting of isoniazid, refampin and ethambutol.
What problem does this paper attempt to address?